• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尼日利亚良性前列腺增生症的全外显子组测序显示凋亡途径的改变增加。

Whole-exome sequencing of Nigerian benign prostatic hyperplasia reveals increased alterations in apoptotic pathways.

机构信息

Center for Cancer Research, Tuskegee University, Tuskegee, Alabama, USA.

Prostate Cancer Transatlantic Consortium (CaPTC), Abuja, Wuse Zone 1, Nigeria.

出版信息

Prostate. 2024 Apr;84(5):460-472. doi: 10.1002/pros.24662. Epub 2024 Jan 8.

DOI:
10.1002/pros.24662
PMID:38192023
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10922327/
Abstract

BACKGROUND

Through whole-exome sequencing of 60 formalin-fixed paraffin-embedded Nigerian (NGRn) benign prostatic hyperplasia (BPH) samples, we identified germline and somatic alterations in apoptotic pathways impacting BPH development and progression. Prostate enlargement is a common occurrence in male aging; however, this enlargement can lead to lower urinary tract symptoms that negatively impact quality of life. This impact is disproportionately present in men of African ancestry. BPH pathophysiology is poorly understood and studies examining non-European populations are lacking.

METHODS

In this study, NGRn BPH, normal prostate, and prostate cancer (PCa) tumor samples were sequenced and compared to characterize genetic alterations in NGRn BPH.

RESULTS

Two hundred and two nonbenign, ClinVar-annotated germline variants were present in NGRn BPH samples. Six genes [BRCA1 (92%), HSD3B1 (85%), TP53 (37%), PMS2 (23%), BARD1 (20%), and BRCA2 (17%)] were altered in at least 10% of samples; however, compared to NGRn normal and tumor, the frequency of alterations in BPH samples showed no significant differences at the gene or variant level. BRCA2_rs11571831 and TP53_rs1042522 germline alterations had a statistically significant co-occurrence interaction in BPH samples. In at least two BPH samples, 173 genes harbored somatic variants known to be clinically actionable. Three genes (COL18A1, KIF16B, and LRP1) showed a statistically significant (p < 0.05) higher frequency in BPH. NGRn BPH also had five gene pairs (PKD1/KIAA0100, PKHD1/PKD1, DNAH9/LRP1B, NWD1/DCHS2, and TCERG1/LMTK2) with statistically significant co-occurring interactions. Two hundred and seventy-nine genes contained novel somatic variants in NGRn BPH. Three genes (CABP1, FKBP1C, and RP11-595B24.2) had a statistically significant (p < 0.05) higher alteration frequency in NGRn BPH and three were significantly higher in NGRn tumor (CACNA1A, DMKN, and CACNA2D2). Pairwise Fisher's exact tests showed 14 gene pairs with statistically significant (p < 0.05) interactions and four interactions approaching significance (p < 0.10). Mutational patterns in NGRn BPH were similar to COSMIC (Catalog of Somatic Mutations in Cancer) signatures associated with aging and dysfunctional DNA damage repair.

CONCLUSIONS

NGRn BPH contained significant germline alteration interactions (BRCA2_rs11571831 and TP53_rs1042522) and increased somatic alteration frequencies (LMTK2, LRP1, COL18A1, CABP1, and FKBP1C) that impact apoptosis. Normal prostate development is maintained by balancing apoptotic and proliferative activity. Dysfunction in either mechanism can lead to abnormal prostate growth. This work is the first to examine genomic sequencing in NGRn BPH and provides data that fill known gaps in the understanding BPH and how it impacts men of African ancestry.

摘要

背景

通过对 60 份尼日利亚(NGRn)良性前列腺增生(BPH)福尔马林固定石蜡包埋样本的全外显子组测序,我们确定了影响 BPH 发展和进展的凋亡途径中的种系和体细胞改变。前列腺增大是男性衰老的常见现象;然而,这种增大可能导致下尿路症状,从而对生活质量产生负面影响。这种影响在非洲裔男性中不成比例地存在。BPH 的病理生理学尚未得到很好的理解,缺乏研究非欧洲人群的研究。

方法

在这项研究中,对 NGRn BPH、正常前列腺和前列腺癌(PCa)肿瘤样本进行测序,以描述 NGRn BPH 中的遗传改变。

结果

在 NGRn BPH 样本中存在 202 种非良性、ClinVar 注释的种系变异。有 6 个基因 [BRCA1(92%)、HSD3B1(85%)、TP53(37%)、PMS2(23%)、BARD1(20%)和 BRCA2(17%)] 在至少 10%的样本中发生改变;然而,与 NGRn 正常和肿瘤相比,BPH 样本中基因或变异水平的改变频率没有显著差异。BRCA2_rs11571831 和 TP53_rs1042522 种系改变在 BPH 样本中具有统计学显著的共同发生相互作用。在至少两个 BPH 样本中,173 个基因携带有临床可操作的已知体细胞变异。有三个基因(COL18A1、KIF16B 和 LRP1)在 BPH 中表现出统计学上显著(p<0.05)更高的频率。NGRn BPH 还具有五个基因对(PKD1/KIAA0100、PKHD1/PKD1、DNAH9/LRP1B、NWD1/DCHS2 和 TCERG1/LMTK2)具有统计学显著(p<0.05)的共同发生相互作用。在 NGRn BPH 中有 279 个基因含有新的体细胞变异。有三个基因(CABP1、FKBP1C 和 RP11-595B24.2)在 NGRn BPH 中的改变频率具有统计学显著(p<0.05)升高,有三个基因在 NGRn 肿瘤中显著升高(CACNA1A、DMKN 和 CACNA2D2)。成对 Fisher 精确检验显示有 14 个基因对具有统计学显著(p<0.05)的相互作用,有四个相互作用接近显著(p<0.10)。NGRn BPH 的突变模式与与衰老和功能失调的 DNA 损伤修复相关的 COSMIC(癌症体细胞突变目录)特征相似。

结论

NGRn BPH 存在显著的种系改变相互作用(BRCA2_rs11571831 和 TP53_rs1042522)和增加的体细胞改变频率(LMTK2、LRP1、COL18A1、CABP1 和 FKBP1C),这些改变影响凋亡。正常前列腺的发育是通过平衡凋亡和增殖活动来维持的。这两个机制中的任何一个功能障碍都可能导致前列腺异常生长。这项工作是首次对 NGRn BPH 进行基因组测序,并提供了数据,填补了我们对 BPH 的理解以及它如何影响非洲裔男性的已知空白。

相似文献

1
Whole-exome sequencing of Nigerian benign prostatic hyperplasia reveals increased alterations in apoptotic pathways.尼日利亚良性前列腺增生症的全外显子组测序显示凋亡途径的改变增加。
Prostate. 2024 Apr;84(5):460-472. doi: 10.1002/pros.24662. Epub 2024 Jan 8.
2
Whole-exome Sequencing of Nigerian Prostate Tumors from the Prostate Cancer Transatlantic Consortium (CaPTC) Reveals DNA Repair Genes Associated with African Ancestry.尼日利亚前列腺癌 Transatlantic 联盟(CaPTC)肿瘤的全外显子组测序揭示了与非洲血统相关的 DNA 修复基因。
Cancer Res Commun. 2022 Sep 16;2(9):1005-1016. doi: 10.1158/2767-9764.CRC-22-0136. eCollection 2022 Sep.
3
Genomic analysis of benign prostatic hyperplasia implicates cellular re-landscaping in disease pathogenesis.良性前列腺增生的基因组分析提示细胞再景观重塑与疾病发病机制有关。
JCI Insight. 2019 May 16;5(12):129749. doi: 10.1172/jci.insight.129749.
4
Spatial architectures of somatic mutations in normal prostate, benign prostatic hyperplasia and coexisting prostate cancer.正常前列腺、前列腺增生和共存前列腺癌中体细胞突变的空间结构。
Exp Mol Med. 2024 Feb;56(1):168-176. doi: 10.1038/s12276-023-01140-8. Epub 2024 Jan 4.
5
p53 tumour suppressor gene mutations in benign prostatic hyperplasia and prostate cancer.良性前列腺增生和前列腺癌中的p53肿瘤抑制基因突变
Eur Urol. 1998;34(5):433-40. doi: 10.1159/000019778.
6
The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates.癌性和非癌性前列腺组织中形态正常组织克隆扩增的结构。
Mol Cancer. 2022 Sep 22;21(1):183. doi: 10.1186/s12943-022-01644-3.
7
Transcriptomic analysis of benign prostatic hyperplasia identifies critical pathways in prostatic overgrowth and 5-alpha reductase inhibitor resistance.前列腺增生转录组分析鉴定前列腺过度生长和 5-α 还原酶抑制剂耐药的关键途径。
Prostate. 2024 Apr;84(5):441-459. doi: 10.1002/pros.24661. Epub 2024 Jan 3.
8
CCR2 and CCR5 genes polymorphisms in benign prostatic hyperplasia and prostate cancer.CCR2 和 CCR5 基因多态性与良性前列腺增生和前列腺癌。
Hum Immunol. 2013 Aug;74(8):1003-8. doi: 10.1016/j.humimm.2013.04.031. Epub 2013 Apr 28.
9
Associations of and Genotypes with PSA Levels and Immunophenotype in Benign Prostatic Hyperplasia and Prostate Cancer.和基因型与良性前列腺增生和前列腺癌中 PSA 水平和免疫表型的相关性。
Front Biosci (Landmark Ed). 2024 Jul 19;29(7):256. doi: 10.31083/j.fbl2907256.
10
Alcohol dehydrogenase expression patterns in normal prostate, benign prostatic hyperplasia, and prostatic adenocarcinoma in African American and Caucasian men.非裔美国男性和白种男性正常前列腺、良性前列腺增生及前列腺腺癌中乙醇脱氢酶的表达模式
Prostate. 2022 May;82(6):666-675. doi: 10.1002/pros.24310. Epub 2022 Feb 8.

本文引用的文献

1
Whole-exome Sequencing of Nigerian Prostate Tumors from the Prostate Cancer Transatlantic Consortium (CaPTC) Reveals DNA Repair Genes Associated with African Ancestry.尼日利亚前列腺癌 Transatlantic 联盟(CaPTC)肿瘤的全外显子组测序揭示了与非洲血统相关的 DNA 修复基因。
Cancer Res Commun. 2022 Sep 16;2(9):1005-1016. doi: 10.1158/2767-9764.CRC-22-0136. eCollection 2022 Sep.
2
Hereditary variants of unknown significance in African American women with breast cancer.遗传性不明意义变异在非裔美国乳腺癌女性中的作用。
PLoS One. 2022 Oct 31;17(10):e0273835. doi: 10.1371/journal.pone.0273835. eCollection 2022.
3
Complement activation by autoantigen recognition in the growth process of benign prostatic hyperplasia.
自身抗原识别在良性前列腺增生生长过程中的补体激活作用。
Sci Rep. 2019 Dec 30;9(1):20357. doi: 10.1038/s41598-019-57001-w.
4
Inequities in multi-gene hereditary cancer testing: lower diagnostic yield and higher VUS rate in individuals who identify as Hispanic, African or Asian and Pacific Islander as compared to European.多基因遗传性癌症检测中的不平等现象:与欧洲人相比,自认为是西班牙裔、非裔或亚太裔的个体的诊断产量较低,VUS 率较高。
Fam Cancer. 2019 Oct;18(4):465-469. doi: 10.1007/s10689-019-00144-6.
5
Heritability and genome-wide association study of benign prostatic hyperplasia (BPH) in the eMERGE network.良性前列腺增生(BPH)的遗传性和全基因组关联研究在 eMERGE 网络中。
Sci Rep. 2019 Apr 15;9(1):6077. doi: 10.1038/s41598-019-42427-z.
6
Structure, Function, and Regulation of the Hsp90 Machinery.热休克蛋白 90 机器的结构、功能和调控。
Cold Spring Harb Perspect Biol. 2019 Sep 3;11(9):a034017. doi: 10.1101/cshperspect.a034017.
7
COSMIC: the Catalogue Of Somatic Mutations In Cancer.COSMIC:癌症体细胞突变目录。
Nucleic Acids Res. 2019 Jan 8;47(D1):D941-D947. doi: 10.1093/nar/gky1015.
8
Maftools: efficient and comprehensive analysis of somatic variants in cancer.Maftools:癌症体细胞变异的高效全面分析。
Genome Res. 2018 Nov;28(11):1747-1756. doi: 10.1101/gr.239244.118. Epub 2018 Oct 19.
9
Calcium and Nuclear Signaling in Prostate Cancer.钙与前列腺癌的核信号转导
Int J Mol Sci. 2018 Apr 19;19(4):1237. doi: 10.3390/ijms19041237.
10
Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction.下尿路症状/良性前列腺增生与勃起功能障碍的流行病学及危险因素
Aging Male. 2019 Mar;22(1):12-19. doi: 10.1080/13685538.2018.1434772. Epub 2018 Feb 2.